Navigation Links
Aureus Pharma Announces Date of 2008 Annual User Symposium

PARIS, July 2 /PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life science industry, announced today that the Aureus Pharma 2008 User Symposium will be held in Paris on October 23rd and 24th.

This symposium follows last year's highly successful inaugural event which was attended by many of Aureus' pharmaceutical and biotech customers from both Europe and North America. The symposium included presentations from industry scientists who described their experience and value perception of Aureus' solutions as applied to their discovery research projects. In addition, challenges and requirements for future developments were discussed.

At the 2008 event, Aureus will introduce several new products and services as well as provide users and prospective users with a better understanding of how Aureus technology can be beneficially implemented within their individual organizations.

"The first Aureus Pharma User Symposium was a great opportunity for our customers to discuss and share the benefits of their respective experiences related to knowledge driven discovery," said Jason Theodosiou, President & CEO of Aureus Pharma. "I am looking forward to this year's meeting as a continued dialog to direct and to improve Aureus Pharma's contribution to the life science industry."

For more information regarding Aureus Pharma's 2008 User Symposium, please visit

About Aureus Pharma

Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes including GPCR, Ion Channel, Kinase as well as other critical pharmaceutical topics including ADME/Drug-Drug Interactions and the hERG Channel. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit

Media Contact

Mary Donlan

Director of Marketing

Aureus Pharma

Phone : +33-1-40-18-57-59 / +33-6-76-19-51-77

SOURCE Aureus Pharma
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. QSB Anti-Virulence Platform Inhibits Biofilm Formation by Staphylococcus Aureus MRSA and Candida sp
2. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
3. New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus (MRSA)
4. WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
5. Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications
6. CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
7. Pharmasset Joins Russell 3000 Index
8. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
9. Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
10. Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
11. Alseres Pharmaceuticals, Inc. Raises $5 Million
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):